SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-24-015820
Filing Date
2024-04-11
Accepted
2024-04-11 16:19:47
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-11

Document Format Files

Seq Description Document Type Size
1 ARS esperion2023arproof.pdf ARS 14781814
  Complete submission text file 0001628280-24-015820.txt   20358264
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35986 | Film No.: 24838761
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)